Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
Lauren Kerr(Hudson Institute of Medical Research), Terrance G. Johns(La Trobe University)
Cited by 10
Related Papers
The epidermal growth factor receptor variant <scp>III</scp> (<scp>EGFR</scp>v<scp>III</scp>): where wild things are altered
|FEBS Journal|2013|357
Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor
|Journal of Biological Chemistry|2004|145
Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
|Clinical Cancer Research|2005|103